Dr. Osborne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Dan L Duncan Cancer Center at Baylor College of Medicine
One Baylor Plaza, MS 305
Houston, TX 77030Phone+1 713-798-1641Fax+1 713-798-1990- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1974 - 1977
Johns Hopkins UniversityResidency, Internal Medicine, 1972 - 1974
University of Missouri-Columbia School of MedicineClass of 1972
Certifications & Licensure
TX State Medical License 1977 - 2025
MD State Medical License 1974 - 1991- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer.Xiaoyong Fu, Resel Pereira, Chia-Chia Liu, Carmine De Angelis, Martin J Shea, Sarmistha Nanda, Lanfang Qin, Tamika Mitchell, Maria L Cataldo, Jamunarani Veeraraghavan,...> ;Cell Reports. 2023 Aug 29
- 6 citationsPertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis.Grazia Arpino, Juan de la Haba Rodríguez, Jean-Marc Ferrero, Sabino De Placido, C Kent Osborne, Dirk Klingbiel, Valentine Revelant, Christine Wohlfarth, Raf Poppe, Mot...> ;Clinical Cancer Research. 2023 Apr 14
- 11 citationsIdentifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach.Varduhi Petrosyan, Lacey E Dobrolecki, Lillian Thistlethwaite, Alaina N Lewis, Christina Sallas, Ramakrishnan R Srinivasan, Jonathan T Lei, Vladimir Kovacevic, Predrag...> ;Iscience. 2023 Jan 20
- Join now to see all
Journal Articles
- The Oral Selective Oestrogen Receptor Degrader (SERD) AZD9496 Is Comparable to Fulvestrant in Antagonising ER and Circumventing Endocrine ResistanceRinath Jeselsohn, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff, Nature
Hospital Affiliations
St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas- Ben Taub General HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
